ATC Group: J07BL01 Yellow fever, live attenuated

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J07BL01 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J07 Vaccines
3 J07B Viral vaccines
4 J07BL Yellow fever vaccines
5 J07BL01 Yellow fever, live attenuated

Active ingredients in J07BL01

Active Ingredient

Related product monographs

Document Type Information Source  
 STAMARIL Powder and solvent for suspension for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 YF-VAX Powder for suspension MPI, US: SPL/Old FDA, National Drug Code (US)

Medicines in this ATC group

United States (US)

Austria (AT)

Brazil (BR)

Canada (CA)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Lithuania (LT)

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.